Pharmacoeconomic evaluation on three different anti-hypertensive treatments
10.3969/j.issn.1006-0111.2018.02.021
- VernacularTitle:3种降压治疗方案的药物经济学评价
- Author:
Zhaowei ZHANG
1
;
Tianzi FANG
Author Information
1. 浙江省金华市中心医院药剂科
- Keywords:
fosinopril sodium;
valsartan;
amlodipine besylate tablet;
cost minimization analysis
- From:
Journal of Pharmaceutical Practice
2018;36(2):189-191
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare three different anti-hypertension therapeutic projects by pharmacoeconomic evaluation and to find out the best therapeutic project.Methods Retrospective study was used.120 patients with hypertension were ran-domly assigned to group A(fosinopril sodium),group B(valsartan),group C(amlodipine besylate tablet),the therapeutic effects were observed and were evaluated by cost minimization analysis.Results The total efficiency of A,B,C group were 90·7%, 92·3%,92.1%(P>0.05)respectively.The incidence of adverse reaction were 16.7%,7.7%,13.2%(P>0.05)respective-ly.The costs were 287.3 yuan,378.7 yuan and 320.4 yuan respectively.Conclution The effectiveness of the three groups was similar.In terms of pharmacoeconomics,group A was the best therapeutic project.
